iRhythm Holdings (IRTC) Total Non-Current Liabilities (2015 - 2026)
iRhythm Holdings (IRTC) posted quarterly Total Non-Current Liabilities of $844.2 million for Q1 2026, up 1.63% year-over-year from $830.7 million in Q1 2025, and down 2.56% quarter-over-quarter from $866.4 million in Q4 2025.
iRhythm Holdings (IRTC) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends
iRhythm Holdings (IRTC) has reported Total Non-Current Liabilities for 10 consecutive years, with $844.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 1.63% year-over-year to $844.2 million; the TTM figure through Mar 2026 stood at $844.2 million (up 1.63% YoY), while the FY2025 annual figure was $866.4 million, up 4.14% from the prior year.
- Total Non-Current Liabilities fell to $844.2 million in Q1 2026 per IRTC's latest filing, from $866.4 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $866.4 million in Q4 2025 and bottomed at $183.0 million in Q1 2022.
- Historically, Total Non-Current Liabilities has averaged $539.4 million across 5 years, with a median of $818.6 million in 2024.
- Annual changes were most pronounced in 2024 — Total Non-Current Liabilities soared 311.64% — and 2025, when it increased 1.48%.
- iRhythm Holdings' Total Non-Current Liabilities stood at $207.1 million in 2022, then climbed by 7.21% to $222.0 million in 2023, then surged by 274.7% to $832.0 million in 2024, then grew by 4.14% to $866.4 million in 2025, then decreased by 2.56% to $844.2 million in 2026.
- Business Quant data shows IRTC's Total Non-Current Liabilities at $844.2 million in Q1 2026, $866.4 million in Q4 2025, and $863.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | iRhythm Holdings | 4.23 Bn | 3.64 Bn | 163.21 Mn | 906.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 906.54 Mn |
| Mar 31, 2026 | 844.25 Mn |
| Dec 31, 2025 | 866.39 Mn |
| Sep 30, 2025 | 863.40 Mn |
| Jun 30, 2025 | 850.60 Mn |
| Mar 31, 2025 | 830.71 Mn |
| Dec 31, 2024 | 831.96 Mn |
| Sep 30, 2024 | 819.94 Mn |
| Jun 30, 2024 | 819.06 Mn |
| Mar 31, 2024 | 818.56 Mn |
| Dec 31, 2023 | 222.04 Mn |
| Sep 30, 2023 | 218.96 Mn |
| Jun 30, 2023 | 204.60 Mn |
| Mar 31, 2023 | 198.85 Mn |
| Dec 31, 2022 | 207.10 Mn |
| Sep 30, 2022 | 200.00 Mn |
| Jun 30, 2022 | 190.09 Mn |
| Mar 31, 2022 | 183.04 Mn |
| Dec 31, 2021 | 182.76 Mn |
| Sep 30, 2021 | 181.98 Mn |